{
    "1727345568786141563": {
        "author_id": "62465691",
        "created_at": "2023-11-22T15:17:30.000Z",
        "edit_history_tweet_ids": [
            "1727345568786141563"
        ],
        "entities": {
            "annotations": [
                {
                    "end": 20,
                    "normalized_text": "Pascal Soriot",
                    "probability": 0.5605,
                    "start": 8,
                    "type": "Person"
                },
                {
                    "end": 68,
                    "normalized_text": "Systems Task Force",
                    "probability": 0.4736,
                    "start": 51,
                    "type": "Other"
                },
                {
                    "end": 109,
                    "normalized_text": "Novo Nordisk",
                    "probability": 0.8759,
                    "start": 98,
                    "type": "Organization"
                },
                {
                    "end": 189,
                    "normalized_text": "Task Force",
                    "probability": 0.5109,
                    "start": 180,
                    "type": "Organization"
                }
            ],
            "mentions": [
                {
                    "end": 43,
                    "id": "1299330439065276417",
                    "start": 36,
                    "username": "TheSMI"
                },
                {
                    "end": 89,
                    "id": "735541993456164866",
                    "start": 74,
                    "username": "LarsFruergaard"
                }
            ]
        },
        "id": "1727345568786141563",
        "lang": "en",
        "public_metrics": {
            "bookmark_count": 0,
            "impression_count": 4728,
            "like_count": 7,
            "quote_count": 0,
            "reply_count": 7,
            "retweet_count": 2
        },
        "text": "Our CEO Pascal Soriot, chair of the @TheSMI Health Systems Task Force and @LarsFruergaard, CEO of Novo Nordisk discuss the climate-health crisis, and the transformative action the Task Force is taking to accelerate the delivery of net zero health systems."
    }
}